Original Paper

Brain-Derived Neurotrophic Factor and Its Intracellular Signaling Pathways in Cocaine Addiction
M. Corominas, C. Roncero, M. Ribases, X. Castells, M. Casas

Psychiatry Service, Vall d'Hebron Hospital, Psychiatry Department of the Universitat Autònoma de Barcelona, Barcelona, Spain

Address of Corresponding Author

Neuropsychobiology 2007;55:2-13 (DOI: 10.1159/000103570)

  Key Words

• Cocaine addiction
• Psychostimulant
• Brain-derived neurotrophic factor
• Extracellular signal-regulated protein kinase
• Phosphatidylinositol 3-kinase
• Sensitization
• Conditioning
• Craving
• Relapse

  Abstract

Cocaine addiction is one of the severest health problems faced by western countries, where there is an increasing prevalence of lifelong abuse. The most challenging aspects in the treatment of cocaine addiction are craving and relapse, especially in view of the fact that, at present, there is a lack of effective pharmacological treatment for the disorder. What is required are new pharmacological approaches based on our current understanding of the neurobiological bases of drug addiction. Within the context of the behavioral and neurochemical actions of cocaine, this paper considers the contribution of brain-derived neurotrophic factor (BDNF) and its main intracellular signaling mechanisms, including mitogen-activated protein kinase/extracellular signal-regulated protein kinase (MAPK/ERK) and phosphatidylinositol 3-kinase (PI3K), in psychostimulant addiction. Repeated cocaine administration leads to an increase in BDNF levels and enhanced activity in the intracellular pathways (PI3K and MAPK/ERK) in the reward-related brain areas, which applies especially several days following withdrawal. It has been hypothesized that these neurochemical changes contribute to the enduring synaptic plasticity that underlies sensitized responses to psychostimulants and drug-conditioned memories leading to compulsive drug use and frequent relapse after withdrawal. Nevertheless, increased BDNF levels could also have a role as a protection factor in addiction. The inhibition of the intracellular pathways, ERK and PI3K, leads to a disruption in sensitized responses and conditioned memories associated with cocaine addiction and suggests new, potential therapeutic strategies to explore in the dependence on psychostimulants.

Copyright © 2007 S. Karger AG, Basel

  References

1.

O'Brien CP: A range of research-based pharmacotherapies for addiction. Science 1997;278:66-70.

2.

Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP: Limbic activation during cue-induced cocaine craving. Am J Psychiatry 1999;156:11-18.

3.

Cami J, Farre M: Drug addiction. N Engl J Med 2003;349:975-986.

4.

de Lima MS, de Oliveira Soares BG, Reisser AA, Farrell M: Pharmacological treatment of cocaine dependence: a systematic review. Addiction 2002;97:931-949.

5.

Nestler EJ, Aghajanian GK: Molecular and cellular basis of addiction. Science 1997;278:58-63.

6.

Piazza PV, Le Moal M: Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res Brain Res Rev 1997;25:359-372.

7.

White FJ, Kalivas PW: Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 1998;51:141-153.

8.

Hyman SE, Malenka RC: Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001;2:695-703.

9.

Robinson TE, Berridge KC: Addiction. Annu Rev Psychol 2003;54:25-53.

10.

Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM: It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 2003;26:184-192.

11.

Kalivas PW, Duffy P: Time course of extracellular dopamine and behavioral sensitization to cocaine. 1. Dopamine axon terminals. J Neurosci 1993;13:266-275.

12.

Kalivas PW, Volkow N, Seamans J: Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 2005;45:647-650.

13.

Nestler EJ: Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001;2:119-128.

14.

Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ: Regulation of cocaine reward by CREB. Science 1998;282:2272-2275.

15.

Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ, Lindsay RM, Hyman C: Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci USA 1992;89:11347-11351.

16.

Pierce RC, Pierce-Bancroft AF, Prasad BM: Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/mitogen-activated protein kinase signal transduction cascade. J Neurosci 1999;19:8685-8695.

17.

Grimm JW, Lu L, Hayashi T, Hope BT, Su TP, Shaham Y: Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 2003;23:742-747.

18.

Filip M, Faron-Gorecka A, Kusmider M, Golda A, Frankowska M, Dziedzicka-Wasylewska M: Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal. Brain Res 2006;1071:218-225.

19.

Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR: Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 1999;19:4110-4122.

20.

Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y: A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 2004;24:1604-1611.

21.

Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol JC, Stipanovich A, Caboche J, Lombroso PJ, Nairn AC, Greengard P, Herve D, Girault JA: Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci USA 2005;102:491-496.

22.

Barde YA, Edgar D, Thoenen H: Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1:549-553.

23.

Klein R, Nanduri V, Jing SA, Lamballe F, Tapley P, Bryant S, Cordon-Cardo C, Jones KR, Reichardt LF, Barbacid M: The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 1991;66:395-403.

24.

Johnson JE, Barde YA, Schwab M, Thoenen H: Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 1986;6:3031-3038.

25.

Heerssen HM, Segal RA: Location, location, location: a spatial view of neurotrophin signal transduction. Trends Neurosci 2002;25:160-165.

26.

Kaplan DR, Miller FD: Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000;10:381-391.

27.

Patapoutian A, Reichardt LF: Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 2001;11:272-280.

28.

Berhow MT, Hiroi N, Nestler EJ: Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 1996;16:4707-4715.

29.

Gordon NS, Burke S, Akil H, Watson SJ, Panksepp J: Socially-induced brain 'fertilization': play promotes brain derived neurotrophic factor transcription in the amygdala and dorsolateral frontal cortex in juvenile rats. Neurosci Lett 2003;341:17-20.

30.

Rattiner LM, Davis M, French CT, Ressler KJ: Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci 2004;24:4796-4806.

31.

Yurek DM, Lu W, Hipkens S, Wiegand SJ: BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp Neurol 1996;137:105-118.

32.

Bland ST, Schmid MJ, Der-Avakian A, Watkins LR, Spencer RL, Maier SF: Expression of c-fos and BDNF mRNA in subregions of the prefrontal cortex of male and female rats after acute uncontrollable stress. Brain Res 2005;1051:90-99.

33.

Numan S, Seroogy KB: Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J Comp Neurol 1999;403:295-308.

34.

Thoenen H: Neurotrophins and neuronal plasticity. Science 1995;270:593-598.

35.

Aicardi G, Argilli E, Cappello S, Santi S, Riccio M, Thoenen H, Canossa M: Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain-derived neurotrophic factor. Proc Natl Acad Sci USA 2004;101:15788-15792.

36.

Lee JL, Everitt BJ, Thomas KL: Independent cellular processes for hippocampal memory consolidation and reconsolidation. Science 2004;304:839-843.

37.

Yamada K, Mizuno M, Nabeshima T: Role for brain-derived neurotrophic factor in learning and memory. Life Sci 2002;70:735-744.

38.

Ying SW, Futter M, Rosenblum K, Webber MJ, Hunt SP, Bliss TV, Bramham CR: Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 2002;22:1532-1540.

39.

Adams JP, Sweatt JD: Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 2002;42:135-163.

40.

Curtis J, Finkbeiner S: Sending signals from the synapse to the nucleus: possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth. J Neurosci Res 1999;58:88-95.

41.

Thomas GM, Huganir RL: MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 2004;5:173-183.

42.

Impey S, Obrietan K, Storm DR: Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 1999;23:11-14.

43.

Opazo P, Watabe AM, Grant SG, O'Dell TJ: Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. J Neurosci 2003;23:3679-3688.

44.

Sanna PP, Cammalleri M, Berton F, Simpson C, Lutjens R, Bloom FE, Francesconi W: Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region. J Neurosci 2002;22:3359-3365.

45.

Martin-Iverson MT, Todd KG, Altar CA: Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J Neurosci 1994;14:1262-1270.

46.

Bassareo V, Di Chiara G: Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience 1999;89:637-641.

47.

Carlezon WA Jr, Wise RA: Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 1996;16:3112-3122.

48.

Le Foll B, Diaz J, Sokoloff P: A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Neuroreport 2005;16:175-178.

49.

Lauterborn JC, Rivera S, Stinis CT, Hayes VY, Isackson PJ, Gall CM: Differential effects of protein synthesis inhibition on the activity-dependent expression of BDNF transcripts: evidence for immediate-early gene responses from specific promoters. J Neurosci 1996;16:7428-7436.

50.

Dluzen DE, Gao X, Story GM, Anderson LI, Kucera J, Walro JM: Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp Neurol 2001;170:121-128.

51.

Hall FS, Drgonova J, Goeb M, Uhl GR: Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 2003;28:1485-1490.

52.

Kalivas PW, Stewart J: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 1991;16:223-244.

53.

Robinson TE, Berridge KC: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993;18:247-291.

54.

Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N: Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 2002;22:4654-4662.

55.

Suto N, Austin JD, Tanabe LM, Kramer MK, Wright DA, Vezina P: Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in a D₁ dopamine receptor dependent manner. Neuropsychopharmacology 2002;27:970-979.

56.

Pierce RC, Bari AA: The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev Neurosci 2001;12:95-110.

57.

Filip M, Siwanowicz J: Implication of the nucleus accumbens shell, but not core, in the acute and sensitizing effects of cocaine in rats. Pol J Pharmacol 2001;53:459-466.

58.

Zhang D, Zhang L, Lou DW, Nakabeppu Y, Zhang J, Xu M: The dopamine D₁ receptor is a critical mediator for cocaine-induced gene expression. J Neurochem 2002;82:1453-1464.

59.

Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, White NM, Graybiel AM, White FJ, Tonegawa S: Dopamine D₃ receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D₁ and D₂ receptors. Neuron 1997;19:837-848.

60.

Staley JK, Mash DC: Adaptive increase in D₃ dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 1996;16:6100-6106.

61.

Bordet R, Ridray S, Carboni S, Diaz J, Sokoloff P, Schwartz JC: Induction of dopamine D₃ receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci USA 1997;94:3363-3367.

62.

Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P: BDNF controls dopamine D₃ receptor expression and triggers behavioural sensitization. Nature 2001;411:86-89.

63.

Di Ciano P, Underwood RJ, Hagan JJ, Everitt BJ: Attenuation of cue-controlled cocaine-seeking by a selective D₃ dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 2003;28:329-338.

64.

Vorel SR, Ashby CR Jr, Paul M, Liu X, Hayes R, Hagan JJ, Middlemiss DN, Stemp G, Gardner EL: Dopamine D₃ receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 2002;22:9595-9603.

65.

Sokoloff P, Guillin O, Diaz J, Carroll P, Griffon N: Brain-derived neurotrophic factor controls dopamine D₃ receptor expression: implications for neurodevelopmental psychiatric disorders. Neurotox Res 2002;4:671-678.

66.

Croll SD, Wiegand SJ, Anderson KD, Lindsay RM, Nawa H: Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF. Eur J Neurosci 1994;6:1343-1353.

67.

Mamounas LA, Blue ME, Siuciak JA, Altar CA: Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 1995;15:7929-7939.

68.

Duman RS: Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry 2002;17(suppl 3):306-310.

69.

Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, A Gray N, Zarate CA Jr, Charney DS: Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 2003;53:707-742.

70.

O'Brien CP, Childress AR, McLellan AT, Ehrman R: Classical conditioning in drug-dependent humans. Ann NY Acad Sci 1992;654:400-415.

71.

Bramham CR, Messaoudi E: BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 2005;76:99-125.

72.

Yamada K, Nabeshima T: Brain-derived neurotrophic factor/TrkB signaling in memory processes. J Pharmacol Sci 2003;91:267-270.

73.

Hall J, Thomas KL, Everitt BJ: Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci 2000;3:533-535.

74.

Rattiner LM, Davis M, Ressler KJ: Brain-derived neurotrophic factor in amygdala-dependent learning. Neuroscientist 2005;11:323-333.

75.

Le Foll B, Frances H, Diaz J, Schwartz JC, Sokoloff P: Role of the dopamine D₃ receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci 2002;15:2016-2026.

76.

Uhl GR, Liu QR, Walther D, Hess J, Naiman D: Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am J Hum Genet 2001;69:1290-1300.

77.

Koob GF, Le Moal M: Drug abuse: hedonic homeostatic dysregulation. Science 1997;278:52-58.

78.

Koob GF, Le Moal M: Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci 2005;8:1442-1444.

79.

Pierce RC, Kalivas PW: A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997;25:192-216.

80.

Fuchs RA, Feltenstein MW, See RE: The role of the basolateral amygdala in stimulus-reward memory and extinction memory consolidation and in subsequent conditioned cued reinstatement of cocaine seeking. Eur J Neurosci 2006;23:2809-2813.

81.

Kauer JA: Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol 2004;66:447-475.

82.

Pu L, Liu QS, Poo MM: BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat Neurosci 2006;9:605-607.

83.

Geinisman Y: Structural synaptic modifications associated with hippocampal LTP and behavioral learning. Cereb Cortex 2000;10:952-962.

84.

Meredith GE, Callen S, Scheuer DA: Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res 2002;949:218-227.

85.

Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, Robbins TW: Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann NY Acad Sci 1999;877:412-438.

86.

Frey S, Bergado-Rosado J, Seidenbecher T, Pape HC, Frey JU: Reinforcement of early long-term potentiation (early-LTP) in dentate gyrus by stimulation of the basolateral amygdala: heterosynaptic induction mechanisms of late-LTP. J Neurosci 2001;21:3697-3703.

87.

Karege F, Schwald M, Cisse M: Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002;328:261-264.

88.

Kim DJ, Roh S, Kim Y, Yoon SJ, Lee HK, Han CS, Kim YK: High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett 2005;388:112-115.

89.

Valjent E, Corvol JC, Pages C, Besson MJ, Maldonado R, Caboche J: Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci 2000;20:8701-8709.

90.

Jenab S, Festa ED, Nazarian A, Wu HB, Sun WL, Hazim R, Russo SJ, Quinones-Jenab V: Cocaine induction of ERK proteins in dorsal striatum of Fischer rats. Brain Res Mol Brain Res 2005;142:134-138.

91.

Radwanska K, Caboche J, Kaczmarek L: Extracellular signal-regulated kinases (ERKs) modulate cocaine-induced gene expression in the mouse amygdala. Eur J Neurosci 2005;22:939-948.

92.

Valjent E, Pages C, Herve D, Girault JA, Caboche J: Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 2004;19:1826-1836.

93.

Ferguson SM, Fasano S, Yang P, Brambilla R, Robinson TE: Knockout of ERK1 enhances cocaine-evoked immediate early gene expression and behavioral plasticity. Neuropsychopharmacology 2006;31:2660-2668.

94.

Valjent E, Corvol JC, Trzaskos JM, Girault JA, Herve D: Role of the ERK pathway in psychostimulant-induced locomotor sensitization. BMC Neurosci 2006;7:20.

95.

Sweatt JD: Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 2004;14:311-317.

96.

Miller CA, Marshall JF: Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 2005;47:873-884.

97.

Cardinal RN, Parkinson JA, Lachenal G, Halkerston KM, Rudarakanchana N, Hall J, Morrison CH, Howes SR, Robbins TW, Everitt BJ: Effects of selective excitotoxic lesions of the nucleus accumbens core, anterior cingulate cortex, and central nucleus of the amygdala on autoshaping performance in rats. Behav Neurosci 2002;116:553-567.

98.

Ito R, Dalley JW, Howes SR, Robbins TW, Everitt BJ: Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci 2000;20:7489-7495.

99.

Gerdjikov TV, Ross GM, Beninger RJ: Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats. Behav Neurosci 2004;118:740-750.

100.

Salzmann J, Marie-Claire C, Le Guen S, Roques BP, Noble F: Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. Br J Pharmacol 2003;140:831-838.

101.

Lu L, Hope BT, Dempsey J, Liu SY, Bossert JM, Shaham Y: Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci 2005;8:212-219.

102.

Lu L, Koya E, Zhai H, Hope BT, Shaham Y: Role of ERK in cocaine addiction. Trends Neurosci 2006;29:695-703.

103.

Valjent E, Corbille AG, Bertran-Gonzalez J, Herve D, Girault JA: Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc Natl Acad Sci USA 2006;103:2932-2937.

104.

Mizuno M, Yamada K, Takei N, Tran MH, He J, Nakajima A, Nawa H, Nabeshima T: Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation. Mol Psychiatry 2003;8:217-224.

105.

Izzo E, Martin-Fardon R, Koob GF, Weiss F, Sanna PP: Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization. Nat Neurosci 2002;5:1263-1264.

106.

Zhang X, Mi J, Wetsel WC, Davidson C, Xiong X, Chen Q, Ellinwood EH, Lee TH: PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity. Biochem Biophys Res Commun 2006;340:1144-1150.

  Author Contacts

Dr. Margarita Corominas
Psychiatry Service, Vall d'Hebron Hospital
Escola d'Enfermeria building, 5th floor, Pg. Vall d'Hebron, 119-129
ES-08035 Barcelona (Spain)
Tel. +34 93 489 42 94, Fax +34 93 489 45 87, E-Mail mcoromin@vhebron.net

  Article Information

Received: May 29, 2006
Accepted after revision: December 17, 2006
Published online: June 8, 2007
Number of Print Pages : 12
Number of Figures : 2, Number of Tables : 0, Number of References : 106

  Publication Details

Neuropsychobiology (International Journal of Experimental and Clinical Research in Biological Psychiatry, Pharmacopsychiatry, Biological Psychology/Pharmacopsychology and Pharmacoelectroencephalography)

Vol. 55, No. 1, Year 2007 (Cover Date: June 2007)

Journal Editor: Strik, W. (Bern)
ISSN: 0302-282X (print), 1423-0224 (Online)

For additional information: http://www.karger.com/NPS

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.